Galera Therapeutics Inc (GRTX) Stock Price, Quote, News & History

GRTXOTCQB
$0.1450
At close: Jun 13, 5:00 PM EST
$0.0740
-0.071-48.97%
After Hours: Apr 14, 9:29 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-6.05M
Investing Cash Flow (TTM)
3.50M
Financing Cash Flow (TTM)
635.00K
Free Cash Flow (TTM)
-6.05M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-1.91M

Analyst Rating and Forecast

12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$12.37M
PE Ratio (TTM)
0.16
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.10
Earnings Yield % (TTM)
630.54%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.02

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$6.38M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
347.32K / 298.71K
Day Range
- - -
52 Wk Range
0.02 - 0.15
Market Cap
$16.04M
P/E Ratio
0.16
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Galera Therapeutics Inc is a biopharmaceutical company that historically was focused on developing a portfolio of small-molecule superoxide dismutase (SOD) mimetics to improve radiotherapy in cancer, mainly by reducing one of the common side effects ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Galera Therapeutics (GRTX) stock?

A

You can purchase shares of Galera Therapeutics (OTCQB:GRTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Galera Therapeutics (GRTX) competitors?

A

There are no as such competitors for Galera Therapeutics.

Q

What is the forecast, or price target, for Galera Therapeutics (GRTX) stock?

A

Galera Therapeutics has a consensus price target of $0.35.

Q

What is the current price for Galera Therapeutics (GRTX)?

A

The stock price for Galera Therapeutics (OTCQB: GRTX) is $0.1 last updated April 22, 2026 at 3:50 PM EDT.

Q

Does Galera Therapeutics (GRTX) pay a dividend?

A

There are no upcoming dividends for Galera Therapeutics.

Q

When is Galera Therapeutics (OTCQB:GRTX) reporting earnings?

A

Galera Therapeutics does not have any upcoming earnings scheduled.

Q

Is Galera Therapeutics (GRTX) going to split?

A

There is no upcoming split for Galera Therapeutics.

Q

What sector and industry does Galera Therapeutics (GRTX) operate in?

A

Galera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.